TMCI · Treace Medical Concepts, Inc. · Webcasts, Transcripts & Audio
Market Cap
$292.66M
Shares
65.03M
Volume · Oct 6
109.06K
Avg daily vol (3M)
338.66K
Treace Medical Concepts, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Treace Medical Concepts, Inc. (TMCI), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲52.9%
$33.05M
−$12.13M
'22 Q3
22-11-08
▲48.8%
$49.77M
−$4.41M
'22 Q4
23-03-07
▲45.3%
$42.20M
−$13.45M
'23 Q1
23-05-08
▲40%
$41.95M
−$12.27M
'23 Q2
23-08-08
▲23.3%
$40.76M
−$17.52M
'23 Q3
23-11-09
▲25%
$62.21M
−$6.28M
'23 Q4
24-02-27
▲21.1%
$51.11M
−$18.68M
'24 Q1
24-05-07
▲6%
$44.45M
−$21.21M
'24 Q2
24-08-06
▲10.6%
$45.09M
−$15.36M
'24 Q3
24-11-05
▲10.4%
$68.71M
−$501,000
'24 Q4
25-02-27
▲2.9%
$52.57M
−$15.92M
'25 Q1
25-05-08
▲6.6%
$47.39M
−$17.40M
'25 Q2
25-08-07
▲11.4%
$50.21M
−$16.29M
'25 Q3
25-11-06
▼9%
$62.52M
−$9.39M
'25 Q4
26-02-27
▼10.2%
$47.20M
−$17.96M
'26 Q1
26-05-08
LATEST
▼4.2%
$45.38M
−$15.87M
'26 Q2
26-08-07
Earnings call
FY26 · Q2
2026-08-07
Treace Medical Concepts, Inc. (TMCI) Q2 2026 Earnings Call Transcript
Confident tone
Seasonal Q4 strength
Bunion portfolio adoption
Profitability and cash usage
Revenue
$45.38M
▼ 4.2% YoY Diluted EPS
$-0.24
Gross margin
78.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-08
Treace Medical Concepts, Inc. (TMCI) Q1 2026 Earnings Call Transcript
Positive tone
Revenue decline and mix shift headwinds
SpeedXM midfoot/hindfoot fusion system
2026 full-year guidance reaffirmation
Revenue
$47.20M
▼ 10.2% YoY Diluted EPS
$-0.28
Gross margin
79.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-27
Treace Medical Concepts, Inc. (TMCI) Q4 2025 Earnings Call
Positive tone
Surgeon base expansion and adoption
Cash burn reduction and profitability improvement
2026 mid-year product launches
Revenue
$62.52M*
▼ 9% YoY Gross margin
80.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Conference
Investor event
2026-01-14
Treace Medical Concepts, Inc. (TMCI) January 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q3
2025-11-06
Treace Medical Concepts, Inc. (TMCI) Q3 2025 Earnings Call Transcript
Cautious tone
Portfolio expansion and new bunion systems
Profitability and cost management
2026 outlook and guidance
Revenue
$50.21M
▲ 11.4% YoY Diluted EPS
$-0.26
Gross margin
79.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Treace Medical Concepts, Inc. (TMCI) Q2 2025 Earnings Call Transcript
Confident tone
Back-half outlook and seasonality
Revenue and financial performance
New product launches and expanded portfolio
Revenue
$47.39M
▲ 6.6% YoY Diluted EPS
$-0.28
Gross margin
79.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Treace Medical Concepts, Inc. (TMCI) Q1 2025 Earnings Call Transcript
Confident tone
New Product Launches (Nanoplasty, PerCuplasty, SpeedMTP)
2025 Full-Year Revenue Guidance
Q1 2025 Revenue Performance
Revenue
$52.57M
▲ 2.9% YoY Diluted EPS
$-0.25
Gross margin
79.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Treace Medical Concepts, Inc. (TMCI) Q4 2024 Earnings Call Transcript
Positive tone
Product portfolio expansion across bunion classes
SpeedPlate adoption and fixation mix
Foot and ankle expansion opportunities
Revenue
$68.71M*
▲ 10.4% YoY Gross margin
80.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-05
Treace Medical Concepts, Inc. (TMCI) Q3 2024 Earnings Call Transcript
Positive tone
Nanoplasty 3D MIS system launch
2025 outlook and growth trajectory
Lapiplasty core franchise
Revenue
$45.09M
▲ 10.6% YoY Diluted EPS
$-0.25
Gross margin
80.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Treace Medical Concepts, Inc. (TMCI) Q2 2024 Earnings Call Transcript
Positive tone
R&D pipeline and new product cadence
Core Lapiplasty / flagship franchise
Minimally invasive osteotomy product launches
Revenue
$44.45M
▲ 6% YoY Diluted EPS
$-0.34
Gross margin
80.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Treace Medical Concepts, Inc. (TMCI) Q1 2024 Earnings Call Transcript
Cautious tone
MIS Osteotomy Solutions
SpeedPlate Platform
Product Launches and Pipeline
Revenue
$51.11M
▲ 21.1% YoY Diluted EPS
$-0.30
Gross margin
80.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Treace Medical Concepts, Inc. (TMCI) Q4 2023 Earnings Call Transcript
Confident tone
Profitability and adjusted EBITDA
Revenue growth and market penetration
Direct sales channel expansion and productivity
Revenue
$62.21M*
▲ 25% YoY Gross margin
81.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Treace Medical Concepts, Inc. (TMCI) Q3 2023 Earnings Call Transcript
Revenue
$40.76M
▲ 23.3% YoY Diluted EPS
$-0.28
Gross margin
80.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Treace Medical Concepts, Inc. (TMCI) Q2 2023 Earnings Call Transcript
Revenue
$41.95M
▲ 40% YoY Diluted EPS
$-0.20
Gross margin
81.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Treace Medical Concepts, Inc. (TMCI) Q1 2023 Earnings Call Transcript
Revenue
$42.20M
▲ 45.3% YoY Diluted EPS
$-0.23
Gross margin
80.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-07
Treace Medical Concepts, Inc. (TMCI) Q4 2022 Earnings Call Transcript
Revenue
$49.77M*
▲ 48.8% YoY Gross margin
81.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Treace Medical Concepts, Inc. (TMCI) Q3 2022 Earnings Call Transcript
Revenue
$33.05M
▲ 52.9% YoY Diluted EPS
$-0.22
Gross margin
81.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Treace Medical Concepts, Inc. (TMCI) Q2 2022 Earnings Call Transcript
Revenue
$29.97M
▲ 45.1% YoY Diluted EPS
$-0.31
Gross margin
82.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Treace Medical Concepts, Inc. (TMCI) Q1 2022 Earnings Call Transcript
Revenue
$29.05M
▲ 55.3% YoY Diluted EPS
$-0.16
Gross margin
82.3%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-12
Treace Medical Concepts, Inc. (TMCI) Q4 2021 Earnings Call Transcript
Revenue
$33.44M*
▲ 38.7% YoY Gross margin
83.9%
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Treace Medical Concepts, Inc. (TMCI) Q3 2021 Earnings Call Transcript
Revenue
$21.62M
▲ 51.5% YoY Diluted EPS
$-0.12
Gross margin
80.4%
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Treace Medical Concepts, Inc. (TMCI) Q2 2021 Earnings Call Transcript
Revenue
$20.65M
▲ 166.9% YoY Diluted EPS
$-0.10
Gross margin
80.9%
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-25
Treace Medical Concepts, Inc. (TMCI) Q1 2021 Earnings Call
Revenue
$18.71M
▲ 66.2% YoY Gross margin
82.2%
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–23 of 23 webcasts